Featured Speakers
Ana Radeljevic
CEO
Adventus Partners
Andrew Davis
Vice Chairman
BIOMARCK PHARMACEUTICALS
Ashlyn Roberts
Coalition Manager
INCUBATE COALITION
Benjamin Brod
Global Head Legal, Oncology BD&L and Portfolio Management
NOVARTIS
Chris Vlahos
Global Head, Rare Disease External Innovation
IPSEN
David Brower
Vice President, Head of Business Development
Accent Therapeutics
Deepa Talpade
Vice President, Head, BD&L and Alliance Management, Oncology
BAYER
Douglas Lee
Vice President, BD&L, Head, Digital & Data Science
BAYER
Erik Paulsen
Former United States Representative
Forrester Liddle
Senior Director Head of IP
Jounce Therapeutics
Jeffrey Warmke
Senior Vice President, Global Business Development
DAIICHI SANKYO
John Stanford
Executive Director
INCUBATE COALITION
Julie Grant
General Partner
Canaan
Karen Denton
Vice President, Business Development
Y-MABS THERAPEUTICS
Mark Coflin
Vice President, Head, Global Alliance Management
SIMCERE
Michael Pine
Senior Vice President, BD and Strategy
MEDEXUS
Nigel Sheail
Global Head, M&A and BD&L
NOVARTIS
Patrick Amstutz
CEO
MOLECULAR PARTNERS
Ravi Kiron
Head, BioPharma External Innovation
EMD Serono
Sara Nayeem
Partner
Avoro Ventures
Steve Twait
Vice President, Alliance and Integration Management
ASTRAZENECA
Zachary P. Neeb
Advisor / Portfolio Strategy, Chorus
Eli Lilly and Company